Lantheus Holdings Inc
For the period ended Jun 30, 2024. Filed Jul 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 31, 2024
LNTH$101.62+0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Six Months Ended June 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities | ||
| Net income | $193,139 | $91,324 |
| Adjustments to reconcile net income to net cash flows from operating activities: | ||
| Depreciation, amortization and accretion | 30,264 | 30,375 |
| Impairment of long-lived assets | — | 138,050 |
| Amortization of debt related costs | 2,145 | 2,155 |
| Changes in fair value of contingent assets and liabilities | 100 | (8,975) |
| Provision for excess and obsolete inventory | 1,925 | 3,179 |
| Stock-based compensation | 33,863 | 22,359 |
| Gain on disposal of assets | (6,254) | — |
| Unrealized gain on investment in equity securities | (38,167) | — |
| Charges incurred in connection with acquired IPR&D | 66,000 | — |
| Deferred taxes | (7,629) | (39,616) |
| Long-term indemnification receivable | — | (327) |
| Long-term income tax payable and other long-term liabilities | 1,588 | 1,386 |
| Other | 4,582 | 1,735 |
| Changes in assets and liabilities which provided (used) cash: | ||
| Accounts receivable | (88,028) | (39,078) |
| Inventory | (7,975) | (19,255) |
| Other current assets | 3,166 | (9,260) |
| Other long-term assets | (353) | — |
| Accounts payable | 6,873 | 14,186 |
| Accrued expenses and other liabilities | 16,719 | (112,004) |
| Net cash provided by operating activities | 211,958 | 76,234 |
| Investing activities | ||
| Capital expenditures | (19,448) | (19,865) |
| Acquisition of assets, net | (33,911) | (45,345) |
| Proceeds from sale of assets | 8,000 | — |
| Purchases of investment in equity securities | (78,256) | — |
| Acquisition of exclusive license option | (28,000) | — |
| Net cash used in investing activities | (151,615) | (65,210) |
| Financing activities | ||
| Payments on long-term debt and other borrowings | (628) | (528) |
| Contingent value rights settlement | — | (3,700) |
| Proceeds from stock option exercises | 2,483 | 3,189 |
| Proceeds from issuance of common stock | 1,823 | 940 |
| Payments for minimum statutory tax withholding related to net share settlement of equity awards | (20,424) | (12,621) |
| Net cash used in financing activities | (16,746) | (12,720) |
| Effect of foreign exchange rates on cash, cash equivalents and restricted cash | (213) | 139 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 43,384 | (1,557) |
| Cash, cash equivalents and restricted cash, beginning of period | 715,285 | 417,241 |
| Cash, cash equivalents and restricted cash, end of period | $758,669 | $415,684 |
Condensed Consolidated Statements of Cash Flows (Continued)
| Six Months Ended June 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Reconciliation to amounts within the condensed consolidated balance sheets | ||
| Cash and cash equivalents | $757,018 | $414,076 |
| Restricted cash included in other long-term assets | 1,651 | 1,608 |
| Cash, cash equivalents and restricted cash at end of period | $758,669 | $415,684 |
| Six Months Ended June 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Schedule of non-cash investing and financing activities | ||
| Additions of property, plant and equipment included in liabilities | $7,937 | $9,826 |
| Acquisition of IPR&D included in liabilities | $37,000 | $— |
| Lease liability settled through transfer of lease | $376 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.